Randomized, Multi-Center, Double-Blinded, Placebo Controlled Safety and Early Efficacy Trial of Cryopreserved Cord Blood Derived T-Regulatory Cell Infusions (CK0802) in the Treatment of COVID-19 Induced ARDS. (RESOLVE Trial)

Gladstone, D. E., Howard, C., Lyu, M.-A., Mock, J., Adams, D., Gibbs, K., Li, L., Huang, M., Zeng, K., D’Alessio, F., Herlihy, J., Trevino, S., Hari, P., Sadeghi, T., Parmar, S., Slutsky, A., & Mukherjee, S. (2021). Randomized, Multi-Center, Double-Blinded, Placebo Controlled Safety and Early Efficacy Trial of Cryopreserved Cord Blood Derived T-Regulatory Cell Infusions (CK0802) in the Treatment of COVID-19 Induced ARDS. (RESOLVE Trial). Blood, 138(Supplement 1), 828–828. https://doi.org/10.1182/blood-2021-153616
Authors:
Douglas E. Gladstone
Christopher Howard
Mi-Ae Lyu
Jason R. Mock
Darryl Adams
Kevin W. Gibbs
Li Li
Meixian Huang
Ke Zeng
Franco R. D’Alessio
James Herlihy
Sergio E. Trevino
Parameswaran Hari
Tara Sadeghi
Simrit Parmar
Arthur S. Slutsky
Siddhartha Mukherjee
Affiliated Authors:
Siddhartha Mukherjee
Publication Type:
Article
Unique ID:
10.1182/blood-2021-153616
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: